Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD28/B7 costimulation: a review

E A Greenfield1, K A Nguyen, V K Kuchroo

  • 1Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.

Critical Reviews in Immunology
|October 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The burden of immune-mediated skin disease in inpatients with HIV/AIDS.

The British journal of dermatology·2021
Same author

Adverse events related to ibuprofen treatment for patent ductus arteriosus in premature neonates.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
Same author

Macrophages Promote Growth of Squamous Cancer Independent of T cells.

Journal of dental research·2019
Same author

Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Quaternary Ammonium Compounds as New Sanitizers for Reducing the Spread of the Olive Knot Pathogen on Orchard Equipment.

Plant disease·2019
Same author

Efficacy of Copper and New Bactericides for Managing Olive Knot in California.

Plant disease·2019
Same journal

Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.

Critical reviews in immunology·2026
Same journal

SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma.

Critical reviews in immunology·2026
Same journal

Knockdown of IGF2BP2 Inhibits THBS1 in Regulating the Progression of Oral Squamous Cell Carcinoma: An Integrative Analysis.

Critical reviews in immunology·2026
Same journal

Plasmodium Phosphatidylinositol 4-Kinase Beta (PI4Kβ): An Emerging Target at the Interface of Parasite Biology and Host Immunity.

Critical reviews in immunology·2026
Same journal

Fusion Gene EPHB4-MET Driven by HOXA9 and Exerted Oncogenic Activity in Non-Small Cell Lung Cancer.

Critical reviews in immunology·2026
Same journal

Secreted Phosphoprotein 1 Represents a Therapeutic Target that Promotes the Progression of Ovarian Cancer by Driving M2 Macrophage Infiltration.

Critical reviews in immunology·2026
See all related articles

The B7/CD28/CTLA4 pathway regulates T cell activation. Manipulating this pathway offers potential treatments for autoimmune diseases, transplant rejection, and cancer immunotherapy.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • T cell activation requires specific (TCR-MHC/Antigen) and nonspecific (B7-CD28) signals.
  • CTLA4, a B7 receptor, downregulates T cell proliferation upon activation.
  • B7 ligands (B7-1, B7-2) bind CD28 and CTLA4 with differing affinities and expression.

Purpose of the Study:

  • To explore the dual role of the CD28/B7 costimulatory pathway in immune regulation.
  • To investigate therapeutic strategies by manipulating the CD28/B7 pathway.

Main Methods:

  • Review of existing research on T cell activation and the B7 family.
  • Analysis of the implications of blocking or activating the CD28/B7 pathway.

Main Results:

  • Blocking CD28/B7 can induce immunosuppression for autoimmune diseases and transplantation.

Related Experiment Videos

  • Activating CD28/B7 may enhance anti-tumor immunity.
  • B7-CTLA4 binding suggests a role in maintaining immune tolerance via T cell downregulation.

    • Conclusions:

    • The B7/CD28/CTLA4 pathway is a critical regulator of immune responses, capable of both activation and suppression.
    • Targeting this pathway holds promise for treating diverse immunological conditions.